Serina Therapeutics SER
NYSE SER
$2.00 -0.01 (-0.48%)
As of: Oct 1, 2026 · 3:14 PM EDT

Serina Therapeutics (SER) Convertible Debt (2023 - 2026)

Updated

Serina Therapeutics' Convertible Debt came in at $3.09 million for Q2 2026.

Analysis

Serina Therapeutics (SER) Convertible Debt (2023 - 2026) Analysis & Trends

At the end of FY2025, Serina Therapeutics' Convertible Debt was $2.95 million.

  • Going back by year, Convertible Debt was $2.98 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Serina Therapeutics 32.93 Mn -7.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.09 Mn
Dec 31, 2025 2.95 Mn
Dec 31, 2023 2.98 Mn
API Access

Serina Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=SER&period=max&api_key=YOUR_API_KEY